MassBio is partnering with the Arthur D. Little team on November 2 to host 2026 R&D Reimagined – Techbio Solutions, the ...
Statement from MassBio CEO & President Kendalle Burlin O’Connell on today’s release of proposed COINS Act rules: “Today, the ...
Predicting glucose responses is complex because food, beverages, physical activity, physiology, and treatment can all shape blood glucose levels. On November 12, Larissa Calancie, PhD, will present a ...
We are very excited to invite you to the BVS and BioMed Realty Biotech Biotech Scientific Innovation Expo in Cambridge. Mark your calendars for a great opportunity to connect with industry leaders, ...
Five weeks after the FDA approved a pill that extends survival in metastatic pancreatic cancer, one of the physicians who led ...
Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-based biotech company developing treatments for cardiac ...
SeraCare Life Sciences develops, manufactures, and sells a broad range of biological based materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of ...
Created by scientists for scientists, NEB prioritizes the advancement of science, stewardship of the environment, and giving back to the world around us in everything we do. Since our establishment in ...
The Massachusetts Life Sciences Center is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a ten-year, $1-billion initiative ...
The Center for Women & Enterprise is a nationally known nonprofit organization dedicated to helping people start and grow their businesses. CWE has worked with more than 46,000 Massachusetts, Rhode ...
Advanced therapies are at an inflection point. Programs built on advanced ex vivo platforms are now intersecting with rapidly emerging in vivo approaches, driven by progress in targeted delivery, gene ...
According to the National Institutes of Health (NIH) – National Library of Medicine, biomarkers have many potential applications in oncology, including risk assessment, screening, differential ...